Cargando…

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection

BACKGROUND: Since early 2022, Omicron BA.1 has been eclipsed by BA.2, which was in turn outcompeted by BA.5, which displays enhanced antibody escape properties. METHODS: Here, we evaluated the duration of the neutralizing antibody (Nab) response, up to 18 months after Pfizer BNT162b2 vaccination, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Planas, Delphine, Staropoli, Isabelle, Porot, Françoise, Guivel-Benhassine, Florence, Handala, Lynda, Prot, Matthieu, Bolland, William-Henry, Puech, Julien, Péré, Hélène, Veyer, David, Sève, Aymeric, Simon-Lorière, Etienne, Bruel, Timothée, Prazuck, Thierry, Stefic, Karl, Hocqueloux, Laurent, Schwartz, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Clinical and Translational Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533668/ https://www.ncbi.nlm.nih.gov/pubmed/36228619 http://dx.doi.org/10.1016/j.medj.2022.09.010

Ejemplares similares

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
por: Bruel, Timothée, et al.
Publicado: (2022)

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
por: Saunders, Nell, et al.
Publicado: (2022)

Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients
por: Bruel, Timothée, et al.
Publicado: (2023)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2022)

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2023)

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study
por: Monel, Blandine, et al.
Publicado: (2021)

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
por: Clairon, Quentin, et al.
Publicado: (2023)

HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells
por: Planchais, Cyril, et al.
Publicado: (2019)

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
por: Kernéis, Solen, et al.
Publicado: (2021)

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
por: Dufloo, Jérémy, et al.
Publicado: (2022)

Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission
por: Prazuck, Thierry, et al.
Publicado: (2020)

Impact de la prévalence du COVID-19 des personnels d’établissements médicosociaux sur le risque d’infection des résidents : étude prospective dans 17 EHPAD et MAS
por: Sève, A., et al.
Publicado: (2020)

High Prevalence of Anal and Oral High-Risk Human Papillomavirus in Human Immunodeficiency Virus–Uninfected French Men Who Have Sex With Men and Use Preexposure Prophylaxis
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2019)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2020)

Syncytia formation by SARS‐CoV‐2‐infected cells
por: Buchrieser, Julian, et al.
Publicado: (2021)

Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
por: Jones, Thane, et al.
Publicado: (2023)

High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2020)

Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
por: Planchais, Cyril, et al.
Publicado: (2022)

Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip
por: Prazuck, Thierry, et al.
Publicado: (2020)

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
por: Hubert, Mathieu, et al.
Publicado: (2023)

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study
por: Bruel, Timothée, et al.
Publicado: (2022)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Bruel, Timothée, et al.
Publicado: (2016)

Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
por: Marlet, Julien, et al.
Publicado: (2021)

Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
por: Monel, Blandine, et al.
Publicado: (2017)

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
por: Gallais, Floriane, et al.
Publicado: (2022)

Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial
por: Parienti, Jean-Jacques, et al.
Publicado: (2021)

Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage
por: Péré, Hélène, et al.
Publicado: (2020)

Resurgence of symptomatic Mpox among vaccinated patients: First clues from a new-onset local cluster
por: Jamard, S., et al.
Publicado: (2023)

Lopinavir to atazanavir or darunavir switch in HIV-1-infected patients with dyslipidemia: an observational study
por: Le Moal, G, et al.
Publicado: (2010)

The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
por: Casartelli, Nicoletta, et al.
Publicado: (2010)

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
por: Flahault, Adrien, et al.
Publicado: (2022)

QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence
por: Handala, Lynda, et al.
Publicado: (2019)

HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer
por: Malbec, Marine, et al.
Publicado: (2013)

Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway
por: Joubert, Pierre-Emmanuel, et al.
Publicado: (2015)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses
por: Helle, Francois, et al.
Publicado: (2020)

In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
por: Romano, Alessandra, et al.
Publicado: (2022)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients
por: Gubavu, Camelia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e8fnhfbpqnn52gd8gmmritnkid